<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated the efficacy and safety of <z:chebi fb="0" ids="40237">sitagliptin</z:chebi> after 3 months' treatment in Japanese type 2 diabetic patients and examined changes in clinical factors </plain></SENT>
<SENT sid="1" pm="."><plain>Baseline HbA1c, <z:chebi fb="73" ids="53262">PPG</z:chebi>, BMI, and duration of <z:mp ids='MP_0002055'>diabetes</z:mp> may be predictors of HbA1c reduction when using <z:chebi fb="0" ids="40237">sitagliptin</z:chebi> in Japanese type 2 diabetic patients </plain></SENT>
</text></document>